FTL and lung carcinoma: In this study, five biomarkers (FTL: ferritin light chain; MAPK1IP1L: mitogen-activated protein kinase 1 interacting protein 1-like; FGB: fibrinogen beta chain; RAB33B: RAB33B, member RAS oncogene family; RAB15: RAB15, member RAS oncogene family) could distinguish lung cancer patients from healthy individuals [69].